ACT#001 CAR-T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ACT#001 CAR-T cells, covering 2025-11-21 to 2025-11-21. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer [EARLY_Phase 1]